Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin in patients with acute myocardial infarction
IRCT20230501058035N2Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of empagliflozin in myocardial infarction (MI), sponsored by Hamadan University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
empagliflozin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20230501058035N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230501058035N2.